Ignite Creation Date:
2024-05-05 @ 9:45 PM
Last Modification Date:
2024-10-26 @ 10:09 AM
Study NCT ID:
NCT00958971
Status:
COMPLETED
Last Update Posted:
2020-12-19
First Post:
2009-08-11
Brief Title:
Safety and Efficacy of TKI258 in FGFR1 Amplified and Non-amplified Metastatic HER2 Negative Breast Cancer
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis